BAMCO INC /NY/ - WUXI PHARMATECH CAYMAN INC ownership

WUXI PHARMATECH CAYMAN INC's ticker is WX and the CUSIP is 929352102. A total of 157 filers reported holding WUXI PHARMATECH CAYMAN INC in Q3 2014. The put-call ratio across all filers is 1.17 and the average weighting 0.3%.

Quarter-by-quarter ownership
BAMCO INC /NY/ ownership history of WUXI PHARMATECH CAYMAN INC
ValueSharesWeighting
Q3 2015$14,756,000
+2.2%
341,5000.0%0.07%
+17.5%
Q2 2015$14,432,000
+9.0%
341,5000.0%0.06%
+11.8%
Q1 2015$13,243,000
+56.4%
341,500
+35.8%
0.05%
+50.0%
Q4 2014$8,468,000
+20.0%
251,500
+24.8%
0.03%
+17.2%
Q3 2014$7,057,000
+6.6%
201,5000.0%0.03%
+11.5%
Q2 2014$6,621,000
-14.7%
201,500
-4.3%
0.03%
-18.8%
Q1 2014$7,759,000
+20.9%
210,500
+25.9%
0.03%
+18.5%
Q4 2013$6,417,000
+1277.0%
167,200
+883.5%
0.03%
+1250.0%
Q3 2013$466,000
+0.9%
17,000
-22.7%
0.00%
+100.0%
Q2 2013$462,00022,0000.00%
Other shareholders
WUXI PHARMATECH CAYMAN INC shareholders Q3 2014
NameSharesValueWeighting ↓
PSquared Asset Management AG 171,495$7,410,00032.67%
Newport Asia LLC 714,600$30,877,00012.95%
Coupland Cardiff Asset Management LLP 45,000$1,944,0006.29%
NINE MASTS CAPITAL Ltd 525,985$22,730,0005.83%
MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC 2,694,589$116,433,0005.17%
PACIFIC ALTERNATIVE ASSET MANAGEMENT COMPANY, LLC 220,131$9,512,0004.79%
Sensato Investors LLC 549,341$23,737,0004.44%
Grandeur Peak Global Advisors, LLC 396,743$17,143,0003.83%
Taconic Capital Advisors LP 2,150,000$92,902,0003.43%
Central Asset Investments & Management Holdings (HK) Ltd 68,815$2,973,0003.26%
View complete list of WUXI PHARMATECH CAYMAN INC shareholders